Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Chronic Pain on Delay Discounting in Methadone Patients
NCT04473950Phase 1Terminated
- Sponsor
- University of California, San Francisco
- Start
- Jan 2020
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of naloxone in opioid use disorder (OUD) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Delay Discounting of Money Rate (k). Started Jan 2020; status: terminated.
02
Drugs
naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04473950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04473950.